The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 22, 2023
Filed:
Nov. 14, 2018
Applicants:
Children's Medical Center Corporation, Boston, MA (US);
Dana-farber Cancer Institute, Inc., Boston, MA (US);
Inventors:
Ofer Levy, Cambridge, MA (US);
David J. Dowling, Brighton, MA (US);
Francesco Borriello, Jamaica Plain, MA (US);
David A. Scott, Newton, MA (US);
Spencer E. Brightman, San Diego, CA (US);
Frederic Feru, Boston, MA (US);
Assignees:
Children's Medical Center Corporation, Boston, MA (US);
Dana-Farber Cancer Institute, Inc., Boston, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); C07D 487/04 (2006.01); A61K 39/39 (2006.01); A61K 9/127 (2006.01); A61K 39/00 (2006.01); A61K 39/008 (2006.01); A61K 39/015 (2006.01); A61K 39/112 (2006.01); A61K 39/02 (2006.01); A61K 39/04 (2006.01); A61K 39/05 (2006.01); A61K 39/08 (2006.01); A61K 39/09 (2006.01); A61K 39/095 (2006.01); A61K 39/102 (2006.01); A61K 39/12 (2006.01); A61K 39/145 (2006.01); A61K 39/165 (2006.01); A61K 39/20 (2006.01); A61K 39/21 (2006.01); A61K 39/245 (2006.01); A61K 39/29 (2006.01); A61K 47/02 (2006.01); C07D 403/04 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 9/127 (2013.01); A61K 39/0003 (2013.01); A61K 39/008 (2013.01); A61K 39/015 (2013.01); A61K 39/0275 (2013.01); A61K 39/0291 (2013.01); A61K 39/04 (2013.01); A61K 39/05 (2013.01); A61K 39/08 (2013.01); A61K 39/092 (2013.01); A61K 39/095 (2013.01); A61K 39/099 (2013.01); A61K 39/102 (2013.01); A61K 39/107 (2013.01); A61K 39/12 (2013.01); A61K 39/145 (2013.01); A61K 39/165 (2013.01); A61K 39/20 (2013.01); A61K 39/21 (2013.01); A61K 39/245 (2013.01); A61K 39/29 (2013.01); A61K 39/292 (2013.01); A61K 47/02 (2013.01); C07D 487/04 (2013.01); A61K 31/519 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55511 (2013.01); C07D 403/04 (2013.01);
Abstract
Provided herein are imidazopyrimidine compounds, such as compounds of Formula (I), for use in enhancing human immune response and/or as adjuvants in vaccines.